TAT Technologies Ltd.

Foreign Filer Report • Aug 12, 2025

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

F O R M 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025

TAT TECHNOLOGIES LTD.

(Name of Registrant)

Hamelacha 5, Netanya 4250540, Israel (Address of Principal Executive Office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐ No ☒

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ____________

TAT Technologies Ltd.

TAT Technologies Ltd. (the "Company") hereby furnishes the following documents:

Item/Exhibit No.	Description
99.1	Unaudited condensed consolidated financial statements as of June 30, 2025 and for the three and six months ended June 30, 2025 and 2024
99.2	Operating and financial review prospects

This Report on Form 6-K and related exhibits are incorporated by reference into the Company's registration statements on Form F-3 (File No. 333-286699) and Form S-8 (File Nos.333-268906, and 333-286702), and shall be a part thereof from the date on which this Form 6-K is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

TAT TECHNOLOGIES LTD. (Registrant)

By: /s/ Ehud Ben-Yair Ehud Ben-Yair Chief Financial Officer

Date: August 11, 2025

TAT TECHNOLOGIES LTD.

UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS For the Period Ended June 30, 2025

TABLE OF CONTENTS

	Page
Financial statements
Unaudited Condensed Consolidated Balance Sheets	F - 2
Unaudited Condensed Consolidated Statements of Income	F - 3
Unaudited Condensed Consolidated Statements of Comprehensive Income	F - 4
Unaudited Condensed Consolidated Statements of Changes in Shareholders' Equity	F - 5
Unaudited Condensed Consolidated Statements of Cash Flows	F - 7
Unaudited Condensed Notes to Financial Statements	F - 8

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

U.S dollars in thousands

	June 30, 2025	December 31, 2024
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	\$ 43,126	\$ 7,129
Short-term bank deposits	57	-
Accounts receivable, net of allowance for credit losses of \$425 and \$400 as of June 30, 2025, and December 31, 2024, respectively	32,266	29,697
Inventory	76,414	68,540
Prepaid expenses and other current assets	6,610	7,848
Total current assets	158,473	113,214
NON-CURRENT ASSETS:
Property, plant and equipment, net	44,646	41,576
Operating lease right of use assets	3,475	2,282
Intangible assets, net	1,558	1,553
Investment in affiliates	4,188	2,901
Funds in respect of employee rights upon retirement	709	654
Deferred income taxes	295	877
Restricted deposit	291	305
Total non-current assets	55,162	50,148
Total assets	\$ 213,635	\$ 163,362
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
Current maturities of long-term loans	\$ 2,088	\$ 2,083
Short-term loans	-	4,350
Accounts payable	15,564	12,158
Accrued expenses and other	15,273	18,594
Current maturities of operating lease liabilities	993	939
Total current liabilities	33,918	38,124
NON-CURRENT LIABILITIES:
Long-term loans	10,310	10,938
Liability in respect of employee rights upon retirement	1,098	986
Operating lease liabilities	2,528	1,345
Total non-current liabilities	13,936	13,269
COMMITMENTS AND CONTINGENCIES (NOTE 4)	-	-
Total liabilities	47,854	51,393
SHAREHOLDERS' EQUITY:
Ordinary shares of NIS 0 par value at June 30, 2025 and at December 31, 2024 respectively Authorized: 15,000,000 shares at June 30, 2025 and 13,000,000 at December 31, 2024; Issued: 13,161,762 and 11,214,831 shares at June 30, 2025 and at
December 31, 2024, respectively; Outstanding: 12,887,289 and 10,940,358 shares at June 30, 2025 and at December 31, 2024, respectively Additional paid-in capital	- 135,578	- 89,697
Treasury stock at cost	(2,088)	(2,088)
Accumulated other comprehensive income (loss)	600	(76)
Retained earnings	31,691	24,436
Total shareholders' equity	165,781	111,969
Total liabilities and shareholders' equity	\$ 213,635	\$ 163,362

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME

U.S dollars in thousands

	Three Months ended June 30,			Six Months ended June 30,
	2025	2024		2025		2024
Revenues:
Products	\$ 12,463	\$	11,732	\$ 25,187	\$	23,667
Services	30,641		24,793	60,059		46,946
	43,104		36,525	85,246		70,613
Cost of goods:
Products	9,112		7,673	17,443		16,659
Services	23,167		20,868	47,024		38,904
	32,279		28,541	64,467		55,563
Gross profit	10,825		7,984	20,779		15,050
Operating expenses:
Research and development, net	240		343	564		620
Selling and marketing	2,185		1,993	4,113		3,653
General and administrative	3,965		2,916	7,497		6,225
Other income	-		(2)	-		(390)
	6,390		5,250	12,174		10,108
Operating income	4,435		2,734	8,605		4,942
Interest expenses	(324)		(413)	(659)		(763)
Other financial income (expenses), net	(776)		106	(499)		7
Income before taxes on income (taxes benefit)	3,335		2,427	7,447		4,186
Provision for taxes on income (taxes benefit)	211		44	803		(109)
Profit before share of equity investment	3,124		2,383	6,644		4,295
Share in profits of equity investment of affiliated companies	318		234	611		432
Net income	\$ 3,442	\$	2,617	\$ 7,255	\$	4,727
Earnings per share
Basic	\$ 0.30	\$	0.26	\$ 0.65	\$	0.46
Diluted	\$ 0.30	\$	0.25	\$ 0.64	\$	0.44
Weighted average number of shares outstanding Basic	11,447,986	10,394,654		11,196,992		10,386,859
Diluted	11,666,309	10,561,420		11,409,488		10,722,153

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

U.S dollars in thousands
	Three Months Ended June 30,				Six Months Ended June 30,
	2025 2024		2025		2024
Net income	\$	3,442	\$	2,617	\$	7,255	\$	4,727
Other comprehensive income (loss), net
Net unrealized losses from derivatives		-		-		-		(27)
Change in foreign currency translation adjustments		148		164		676		164
Total comprehensive income	\$	3,590	\$	2,781	\$	7,931	\$	4,864

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY

U.S dollars in thousands, except share data

	Share capital			Accumulated other
	Number of shares issued	Amount		Additional paid-in capital		comprehensive income (loss)		Treasury shares	Retained earnings	Total equity
BALANCE AT DECEMBER 31, 2023	10,377,085	3,140 \$	\$	76,335	\$	27	\$	(2,088)	\$ 13,269	\$ 90,683
CHANGES DURING THE 6 MONTHS ENDED JUNE 30, 2024:
Comprehensive income	-	-		-		137		-	4,727	4,864
Exercise of option	49,109	12		(12)		-		-	-	-
Share based compensation	-	-		189		-		-	-	189
BALANCE AT JUNE 30, 2024	10,426,194	3,152		76,512		164		(2,088)	17,996	95,736
BALANCE AT DECEMBER 31, 2024	11,214,831	-		89,697		(76)		(2,088)	24,436	111,969
CHANGES DURING THE 6 MONTHS ENDED JUNE 30, 2025:
Comprehensive income	-	-		-		676		-	7,255	7,931
Exercise of option	79,633	-		-		-		-	-	-
Issuance of common shares on public offering, net of issuance costs of \$2,769	1,625,000	-		39,415		-		-	-	39,415
Exercise of the underwriters' option on public offering, net of issuance costs of \$413	242,298	-		5,953		-		-	-	5,953
Share based compensation	-	-		513		-		-	-	513
BALANCE AT JUNE 30, 2025	13,161,762	- \$	\$	135,578	\$	600	\$	(2,088)	\$ 31,691	\$ 165,781

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY

U.S dollars in thousands, except share data

	Share capital				Accumulated other
	Number of shares issued		Amount		Additional paid-in capital		comprehensive income		Treasury shares	Retained earnings	Total equity
BALANCE AT MARCH 31, 2024	10,382,637	\$	3,141	\$	76,376	\$	-	\$	(2,088)	\$ 15,379	\$ 92,808
CHANGES DURING THE 3 MONTHS ENDED JUNE 30, 2024:
Comprehensive income	-		-		-		164		-	2,617	2,781
Exercise of option	43,557		11		(12)		-		-	-	(1)
Share based compensation	-		-		148		-		-	-	148
BALANCE AT JUNE 30, 2024	10,426,194		3,152		76,512		164		(2,088)	17,996	95,736
BALANCE AT MARCH 31, 2025	11,214,831		-		89,919		452		(2,088)	28,249	116,532
CHANGES DURING THE 3 MONTHS ENDED JUNE 30, 2025:
Comprehensive income	-		-		-		148		-	3,442	3,590
Exercise of stock option	79,633		-		-		-		-	-	-
Issuance of common shares on public offering, net of issuance costs of \$2,769	1,625,000		-		39,415		-		-	-	39,415
Exercise of the underwriters' option on public offering, net
of issuance costs of \$413	242,298		-		5,953		-		-	-	5,953
Share based compensation	-		-		291		-		-	-	291
BALANCE AT JUNE 30, 2025	13,161,762	\$	-	\$	135,578	\$	600	\$	(2,088)	\$ 31,691	\$ 165,781

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

U.S. dollars in thousands

	Three Months Ended June 30,					Six Months Ended June 30,
		2025		2024	2025			2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	\$	3,442	\$	2,617	\$	7,255	\$	4,727
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization		1,208		1,431		2,513		2,805
Non-cash financial (income) expenses		600		(276)		508		(486)
Change in allowance for credit losses		75		40		25		40
Share in profits of equity investment of affiliated companies		(318)		(234)		(611)		(432)
Share based compensation		291		148		513		189
Gain on disposal of property, plant and equipment		-		(1)		-		(355)
Deferred income taxes, net		63		306		582		(103)
Changes in operating assets and liabilities:
Decrease (increase) in trade accounts receivable		882		(5,430)		(2,594)		(6,250)
Decrease (increase) in prepaid expenses and other current assets		1,697		(129)		1,183		(283)
Increase in inventory		(3,434)		(2,906)		(7,295)		(5,543)
Increase (decrease) in trade accounts payable		2,972		(209)		3,406		(909)
Decrease (increase) in accrued expenses and other		(529)		543		(3,571)		(1,047)
Net cash provided by (used in) operating activities		6,949		(4,100)		1,914		(7,647)
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sale of property and equipment		-		-		-		1,306
Purchase of property and equipment		(3,305)		(978)		(6,167)		(1,967)
Net cash used in investing activities		(3,305)		(978)		(6,167)		(661)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayments of long-term loans		(516)		(510)		(1,087)		(950)
Proceeds from issuance of ordinary shares and exercise of the underwriters' option		48,550		(1)		48,550		-
Issuance costs of ordinary shares and exercise of the underwriters' option		(2,820)		-		(2,820)		-
Net change in short term loans from banks		(10,719)		4,668		(4,350)		668
Net cash provided by (used in) financing activities		34,495		4,157		40,293		(282)
Net increase (decrease) in cash and cash equivalents and restricted cash		38,139		(921)		36,040		(8,590)
Cash and cash equivalents and restricted cash at beginning of period		5,335		9,273		7,434		16,942
Cash and cash equivalents and restricted cash at the end of period	\$	43,474	\$	8,352	\$	43,474	\$	8,352
Supplementary information on investing and financing activities not involving cash flows:
Additions of operating lease right-of-use assets and operating lease liabilities	\$	1,688	\$	245	\$	1,835	\$	590
Reclassification between inventory and property, plant and equipment		-		-		579		60
Unpaid issuance costs of ordinary shares and exercise of the underwriters' option		362		-		362		-
Supplemental disclosure of cash flow information:
Interest paid		249		410		516		852

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

U.S. dollars in thousands

NOTE 1 - GENERAL

TAT Technologies Ltd., ("TAT" or the "Company") an Israeli corporation, incorporated in 1985, is a leading provider of solutions and services to the aerospace and defense industries, focused on the following four segments: (i) Original Equipment Manufacturing ("OEM") of heat transfer solutions and aviation accessories mainly through our Kiryat Gat facility ; (ii) Maintenance Repair and Overhaul ("MRO") services for heat transfer components and OEM of heat transfer solutions through Limco Airepair Inc.; a wholly owned Delaware subsidiary of Limco-Piedmont Inc.; (iii) MRO services for aviation components (mainly Auxiliary Power Unit ("APU") and Landing Gear ("LG")) through Piedmont Aviation Component Services ., a wholly owned Delaware subsidiary of Limco-Piedmont Inc.; and (iv) overhaul and coating of jet engine components through Turbochrome LTD our wholly-owned subsidiary. TAT targets the commercial aerospace (serving a wide range of types and sizes of commercial and business jets), military aerospace and ground defense sectors. TAT's shares are listed on both the NASDAQ (TATT) and Tel-Aviv Stock Exchange ("TAT Tech").

TAT has the following wholly owned subsidiaries: Limco-Piedmont Inc. ("Limco-Piedmont"), Limco Airepair Inc., a wholly owned Delaware subsidiary of Limco-Piedmont, Piedmont Aviation Component Services LLC, a North Carolina limited liability company, wholly owned subsidiary of Limco-Piedmont Inc., and Turbochrome Ltd. ("Turbochrome"). Additionally, the Company holds 51% of TAT-Engineering LLC, which was established in January 2016 ("TAT-Engineering") as a joint venture, hereinafter collectively referred to as the "Group". The accounting treatment of the joint venture is based on the equity method due to variable participating rights granted to TAT Engineering.

In October 2023, Hamas terrorists infiltrated Israel's southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Following the attack by Hamas on Israel's southern border, Hezbollah in Lebanon has also launched missile, rocket, and shooting attacks against Israeli military sites, troops, and Israeli towns in Northern Israel. Following the attacks, Israel's security cabinet declared war against Hamas and a military campaign against these terrorist organizations commenced in parallel to their continued rocket and terror attacks. In addition, Israel faces threats from more distant neighbors such as terrorist groups in Yemen, which attached Israel and limited the movement of marine shipments to Israel through the Red Sea. Further, in June 2025, the Israel's security cabinet declared a military operation against Iran, while Iran, in retaliation, launched hundreds of ballistic missiles toward Israel, some of which reached central areas. While most were intercepted by Israel's multi-layered air defense systems, injuries were reported, and several casualties occurred. To date, the Company's operations and financial results have not been materially affected. The Company expects that the current conflict in the Gaza Strip will not have a material impact on its business results in the short term. However, the intensity and duration of Israel's current war is difficult to predict, as are such war's economic implications on our business and operations and on Israel's economy in general.

Also, since this is an event beyond the Company's control and may impact our Israeli activity, its continuation or cessation may affect our expectations. The Company continues to monitor its ongoing activities and will make any needed adjustments to ensure continuity of its business, while supporting the safety and well-being of its employees. For the three and six months ended on June 30, 2025, the Group's activity in Israel contributed \$11,860 and \$24,132 out of total revenue of \$43,104 and \$85,246, respectively.

Furthermore, during 2025, global conflicts continue to create volatility in global financial and energy markets and contribute to supply chain shortages adding to the inflationary pressures in the global economy. These lead to higher material and labor costs, and as a result the Company decided to retain higher inventory levels. The Company actively collaborates with its suppliers to minimize the impacts of supply shortages on manufacturing and MRO services.

International operations are subject to a number of other risks, including import and export laws and the impact of tariffs. Changes in global tariff regimes, whether recently implemented or anticipated, may have broader implications for the Company's operations. These may include increased volatility in purchasing prices due to shifting import costs, particularly with respect to raw materials and components sourced internationally. Furthermore, elevated tariffs can affect the pricing structure and profitability of cross-border transactions, potentially requiring adjustments to existing contracts with customers and suppliers located outside of the United States. While the full impact of these tariffs remains uncertain, since the Company serves its U.S. customers from production facilities in the U.S., the Company has ability to negotiate, and the tariffs will be substantially pass to customers. The Company is expecting minimal to no impact from the changes above.

U.S. dollars in thousands

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES

a. Basis of Presentation

The accompanying interim consolidated balance sheet as of June 30, 2025, the interim consolidated statements of income, interim statements of cash flows and the interim consolidated statements of shareholders' equity for the three and six months ended June 30, 2025 and 2024 are unaudited. These unaudited interim consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("U.S. GAAP") and applicable rules and regulations of the Securities and Exchange Commission regarding interim financial reporting.

In management's opinion, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for the fair statement of the Company's financial position as of June 30, 2025, as well as its results of operations and cash flows for the three and six months ended June 30, 2025 and 2024.

The results of operations for the three and six months ended June 30, 2025 are not necessarily indicative of the results to be expected for the year ending December 31, 2025, or for other interim periods or for future years.

The accompanying unaudited interim financial statements should be read in conjunction with the Company's Annual Report on Form 20-F for the fiscal year ended December 31, 2024 (the "2024 Annual Report") filed with the Securities and Exchange Commission (the "SEC") on March 26, 2025.

b. Fair value measurement

The Group measures fair value and discloses fair value measurements for financial assets and liabilities. Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The accounting standard establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:

• Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.
• Level 2: Observable prices that are based on inputs not quoted on active markets but corroborated by market data or active market data for similar but not identical assets or liabilities.
• Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.

U.S. dollars in thousands

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (CONT)

In determining fair value, the Group utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and considers credit risk in its assessment of fair value. During 2024, the Company ceased its hedging activity. Currently, the Company does not hold financial instruments measured at fair value on a recurring basis. The Company's financial instruments consist mainly of cash and cash equivalents, restricted deposits, accounts receivable, accounts payable, accrued expenses and other liabilities. The fair value of these financial instruments approximates their carrying value.

c. Significant Accounting Policies

There have been no changes to the significant accounting policies described in the 2024 Annual Report that have had a material impact on the unaudited interim consolidated financial statements and related

d. Use of Estimates

notes.

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclose the nature of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting years. Actual results could differ from those estimates.

As applicable to these financial statements, the most significant estimates and assumptions relate to recoverability of inventory, provision for current expected credit loss, and income taxes.

e. Concentrations of Credit Risk

Financial instruments that potentially subject the Group to concentrations of credit risk consist principally of cash and cash equivalents and deposits, derivatives and accounts receivable.

Cash and cash equivalents are deposited with several major banks in Israel and the United States. Such deposits in the United States and Israel may be in excess of insured limits and are not insured in other jurisdictions. Management believes that the financial institutions that hold the Group's cash and cash equivalents are financially sound, and that the Group has not been affected by certain banking institutions in the U.S. Accordingly, minimal credit risk exists with respect to these financial instruments.

The Group has a relatively large number of customers with established private and public companies, and governmental institutions which mitigates the credit risk. The Group performs ongoing credit evaluation of its customers' financial condition. As part of the risk management, the Company purchased a credit insurance policy from a well-known insurance Company. As of June 30, 2025 and December 31, 2024 the Company has a single customer which represents 12.5% and 24% of the Company's accounts receivable, respectively.

f. Recently issued accounting pronouncements, not yet adopted

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. The ASU will be effective for fiscal years beginning after December 15, 2025, and allows adoption on a prospective basis, with a retrospective option. The Company is in the process of assessing the impact and method of adoption.

In November 2024, the FASB issued ASU No. 2024-03 Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40). The ASU improves the disclosures about a public business entity's expense and provides more detailed information about the types of expenses in commonly presented expense captions. The amendments require that at each interim and annual reporting period an entity will disclose amounts of purchases of inventory, employee compensation, depreciation and amortization included in each relevant expense caption (such as cost of sales, SG&A and research and development). The ASU is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating this ASU to determine its impact on the Company's disclosures.

$$_{F-10}$$

U.S. dollars in thousands

NOTE 3 - INVENTORY

Inventory is composed of the following:

	June 30, 2025		December 31, 2024
Raw materials and components	\$ 59,755	\$	50,197
Work in progress	15,488		17,382
Finished goods	1,171		961
Total inventory	\$ 76,414	\$	68,540

Inventories write down expenses due to slow inventory amounted to \$590 and \$240 for the periods ended June 30, 2025 and 2024, respectively.

The Company maintains a wide range of exchangeable units and other spare parts related to its products and services in various locations. Due to the long lead time of its suppliers and manufacturing cycles, the Company needs to forecast demand and commit significant resources towards these inventories. As such, the Company is subject to risks including excess inventory no longer relevant.

NOTE 4 - COMMITMENTS AND CONTINGENCIES

a. Royalty commitments

The Group is committed to paying royalties as percentage of revenue or as a percentage of purchase in the amount range from 5% to 25% to certain OEM as part of the Company's licenses agreements. Royalties expense was \$1,090 and \$1,168 for the three months ended June 30, 2025 and 2024, respectively. Royalties expense was \$2,462 and \$2,214 for the six months ended June 30, 2025 and 2024, respectively.

b. Litigation

On July 12, 2022, TAT filed a suit against TAT Industries Ltd. in the District Court of Tel Aviv. TAT had leased the Gedera facility from TAT Industries Ltd. until the termination of the lease agreement in 2022. TAT asserts that TAT Industries Ltd. has unlawfully forfeited a bank guarantee that was granted for the benefit TAT Industries Ltd. in connection with the lease in Gedera in the amount of \$750 thousands. On December 28, 2022, TAT Industries Ltd. filed a counterclaim against TAT asserting damages caused by TAT in connection with the lease in Gedera. TAT intends to vigorously defend the counterclaim by TAT Industries Ltd. which is in a preliminary stage, and TAT cannot estimate at this stage what impact, if any, the litigation may have on its results of operations, financial condition, or cash flows.

c. Leases

During 2025, Piedmont signed a renewal of lease agreement for a facility in Greensboro, North Carolina, U.S., with a lease term that will expire on June 30, 2030. As a result, the Company recognized an operating ROU assets and related operating lease liability of approximately \$1.6 million.

U.S. dollars in thousands

NOTE 5 - EARNINGS PER SHARE ("EPS")

Basic earnings per share are based on the weighted average number of ordinary shares outstanding, net of treasury shares. Diluted EPS is based on those shares used in basic EPS plus shares that would have been outstanding assuming issuance of ordinary shares for all dilutive potential ordinary shares outstanding.

	Three Months Ended June 30,					Six Months Ended June 30,
		2025 2024			2025			2024
Numerator for EPS:
Net income	\$	3,442	\$	2,617	\$	7,255	\$	4,727
Denominator for EPS:
Weighted average shares outstanding – basic		11,447,986		10,394,654		11,196,992		10,386,859
Dilutive shares		218,323		166,766		212,496		335,294
Weighted average shares outstanding – diluted		11,666,309		10,561,420		11,409,488		10,722,153
EPS:
Basic	\$	0.30	\$	0.26	\$	0.65	\$	0.46
Diluted	\$	0.30	\$	0.25	\$	0.64	\$	0.44

NOTE 6 - EQUITY TRANSACTION

a. Stock options

In February 2025, the Board of Directors approved the grant of 230 thousand options to officers and senior executives of the Company under the terms and conditions of the 2012 and 2022 Stock Option Plans. The grants have an exercise price of \$29.93 per share, a grant date fair value of \$3,257 thousand, and will vest over four years of which 25% shall vest after 12 months of the date of grant; and 6.25% shall vest at the end of each 3 months after the first anniversary of the date of grant. The fair value of share-based awards is estimated using the Black-Scholes valuation model and is recognized as stock base compensation expense over the requisite service period, net of estimated forfeitures. The fair value of the share-based awards for the six months ended June 30, 2025 was estimated using the following assumptions: (1) expected volatility of 50.0%, (2) expected option life of 4.6 years, (3) risk free interest rate of 4.5% and (4) dividend yield of 0%.

b. Increase authorized shares

At a special shareholder meeting in March 2025, TAT's shareholders approved the increase of its authorized share capital from 13,000,000 to 15,000,000.

c. Public offering

On June 3, 2025, the Company completed a public offering of 1,625,000 of its ordinary shares, no par value per share, at a public offering price of \$26.00 per share for gross proceeds of \$42.3 million. The issuance costs incurred were \$2.8 million, hence, generating net proceeds of \$39.4 million.

In addition, 2,525,000 ordinary shares were sold by existing shareholders as part of the same offering.

On June 26, 2025, the underwriters exercised in full their option to purchase an additional 242,298 ordinary shares from the Company and 380,202 ordinary shares from selling stockholders at offering price of \$26.00. The issuance costs incurred were \$0.4 million. This resulted in additional net proceeds of approximately \$6.0 million to the Company.

The net proceed for the Company from this public offering after issuance costs is \$45.4 million.

U.S. dollars in thousands

NOTE 7 - SEGMENT INFORMATION

a. Segment Activities Disclosure:

TAT operates under four segments: (i) OEM of heat transfer solutions and aviation accessories mainly through its Kiryat Gat facility; (ii) MRO services for heat transfer components and OEM of heat transfer solutions through its Limco subsidiary; (iii) MRO services for aviation components (mainly APU and LG) through its Piedmont subsidiary; and (iv) Overhaul and coating of jet engine components through its Turbochrome subsidiary.

• OEM of heat transfer solutions and aviation accessories primarily include the design, development and manufacture of (i) broad range of heat transfer solutions, such as pre-coolers heat exchangers and oil/fuel hydraulic heat exchangers, used in mechanical and electronic systems on board of commercial, military and business aircraft; (ii) environmental control and power electronics cooling systems installed on board aircraft in and ground applications; and (iii) a variety of other mechanical aircraft accessories and systems such as pumps, valves, and turbine power units.
• MRO Services for heat transfer components and OEM of heat transfer solutions primarily include the MRO of heat transfer components and to a lesser extent, the manufacturing of certain heat transfer solutions. TAT's Limco subsidiary operates an FAA-certified repair station, which provides heat transfer MRO services for airlines, air cargo carriers, maintenance service centers and the military.
• MRO services for aviation components include the MRO of APUs, landing gears and other aircraft components, as well as APU lease activity. TAT's Piedmont subsidiary operates an FAA-certified repair station, which provides aircraft component MRO services for airlines, air cargo carriers, maintenance service centers and the military.
• TAT's activities in the area of overhaul and coating of jet engine components includes the overhaul and coating of jet engine components, including turbine vanes and blades, fan blades, variable inlet guide vanes and afterburner flaps.

The Group's chief operating decision-maker ("CODM") is the CEO of the Company. The CODM evaluate segment performance and allocate the Company's resources, the CODM uses segment measures of revenue, gross profit, operating income and total assets. The CODM reviews budget-to-actual variances of both profit measures on a monthly basis when making decisions about allocation of the Company's resources to the segments.

U.S. dollars in thousands

NOTE 7 - SEGMENT INFORMATION (CONT)

b. Segments statement operations disclosure:

The following financial information is the information that CODM uses for analyzing the segment results. The following financial information is a summary of the operating income of each operational segment:

Six Months Ended June 30, 2025
OEM of Heat Transfer Solutions and Aviation Accessories		MRO Services for heat transfer components and OEM of heat transfer solutions		MRO services for Aviation Components and Lease		Overhaul and coating of jet engine components		Elimination of inter-Company sales			Consolidated
\$	19,694	\$	22,820	\$	38,294	\$	4,438	\$	-	\$	85,246
	390		845		-		-		(1,235)		-
	13,887		16,962		32,745		2,191		(1,318)		64,467
	6,197		6,703		5,549		2,247		83		20,779
											564
	903		1,136		1,797		277		-		4,113
	2,480		1,739		2,958		320		-		7,497
\$	2,494	\$	3,516	\$	794	\$	1,718	\$	83		8,605
											(1,158)
										\$	7,447
		320		312		-		(68)		-

U.S. dollars in thousands

NOTE 7 - SEGMENT INFORMATION (CONT)

b. Segments statement operations disclosure (cont.)

	Six Months Ended June 30, 2024
	OEM of Heat Transfer Solutions and Aviation Accessories			MRO Services for heat transfer components and OEM of heat transfer solutions		MRO services for Aviation Components and Lease		Overhaul and coating of jet engine components		Elimination of inter-Company sales		Consolidated
Revenues - external	\$	18,382	\$	19,459	\$	29,163	\$	3,609	\$	-	\$	70,613
Revenues - internal		507		1,499		-		-		(2,006)		-
Cost of revenues		12,275		17,632		25,396		2,186		(1,926)		55,563
Gross profit		6,614		3,326		3,767		1,423		(80)		15,050
Research and development		206		155		227		32		-		620
Selling and marketing		1,124		964		1,377		188		-		3,653
General and administrative		2,004		1,673		2,289		259		-		6,225
Other segment expenses (income)		-		(2)		(388)		-				(390)
Operating income	\$	3,280	\$	536	\$	262	\$	944	\$	(80)		4,942
Financial expenses, net												(756)
Income before taxes											\$	4,186

U.S. dollars in thousands

NOTE 7 - SEGMENT INFORMATION (CONT)

b. Segments statement operations disclosure (cont.)

The following financial information is the information that CODM uses for analyzing the segment results. The following financial information is a summary of the operating income of each operational segment:

			Three Months Ended June 30, 2025
	OEM of Heat Transfer Solutions and Aviation Accessories	MRO Services for heat transfer components and OEM of heat transfer solutions	MRO services for Aviation Components and Lease	Overhaul and coating of jet engine components	Elimination of inter-Company sales	Consolidated
Revenues - external	\$ 9,608	\$ 11,248	\$ 19,996	\$ 2,252	\$ -	\$ 43,104
Revenues - internal	53	277	-	-	(330)	-
Cost of revenues	6,714	8,139	16,700	1,083	(357)	32,279
Gross profit	2,947	3,386	3,296	1,169	27	10,825
Research and development	171	172	-	(103)	-	240
Selling and marketing	452	582	1,009	142	-	2,185
General and administrative	1,403	944	1,455	163	-	3,965
Operating income	\$ 921	\$ 1,688	\$ 832	\$ 967	\$ 27	4,435
Financial expenses, net						(1,100)
Income before taxes						\$ 3,335

U.S. dollars in thousands

NOTE 7 - SEGMENT INFORMATION (CONT)

b. Segments statement operations disclosure (cont.)

			Three Months Ended June 30, 2024
	OEM of Heat Transfer Solutions and Aviation Accessories	MRO Services for heat transfer components and OEM of heat transfer solutions	MRO services for Aviation Components and Lease	Overhaul and coating of jet engine components	Elimination of inter-Company sales	Consolidated
Revenues - external	\$ 9,367	\$ 10,220	\$ 15,191	\$ 1,747	\$ -	\$ 36,525
Revenues - internal	222	728			(950)
Cost of revenues	5,936	9,497	12,832	1,101	(825)	28,541
Gross profit	3,653	1,451	2,359	646	(125)	7,984
Research and development	96	91	128	28	-	343
Selling and marketing	470	590	813	120	-	1993
General and administrative	968	757	1,127	64	-	2,916
Other segment expenses (income)	(2)	-	-	-		(2)
Operating income	\$ 2,121	\$ 13	\$ 291	\$ 434	\$ (125)	2,734
Financial expenses, net						(307)
Income before taxes						\$ 2,427

U.S. dollars in thousands

NOTE 7 - SEGMENT INFORMATION (CONT)

c. The following financial information identifies the assets, depreciation and amortization, and capital expenditures to segments:

					Six Months Ended June 30, 2025
	MRO Services OEM of Heat for heat transfer Transfer components and MRO services Overhaul and Solutions and OEM of heat for Aviation coating of jet Aviation transfer Components and engine Accessories solutions Lease components		Amounts not allocated to segments			Consolidated
Total assets	\$ 73,499	\$	43,516	\$	87,423	\$	11,033	\$	(1,836)	\$	213,635
Depreciation and amortization	408		543		1,466		175		(79)		2,513
Expenditure for segment assets	1,502		332		4,167		164		-		6,165
	Year Ended December 31, 2024
	OEM of Heat Transfer Solutions and Aviation Accessories		MRO Services for heat transfer components and OEM of heat transfer solutions		MRO services for Aviation Components and Lease		Overhaul and coating of jet engine components		Amounts not allocated to segments		Consolidated
Total assets	\$ 33,726	\$	40,698	\$	80,014	\$	10,182	\$	(1,258)	\$	163,362
Depreciation and amortization	642		1,040		3,412		388		(27)		5,455

U.S. dollars in thousands

NOTE 8 - REVENUES

a. Total revenues - by geographical location were attributed according to customer residential country as follows:

	Three Months Ended June 30,					Six Months Ended June 30,
	2025 2024			2025		2024
Sale of Products
United States	\$	6,695	\$	6,959	\$	14,676	\$	14,134
Europe		1,344		886		2,487		1,585
Israel		2,523		908		4,294		1,808
Other		1,901		2,979		3,730		6,140
	\$	12,463	\$	11,732	\$	25,187	\$	23,667
		Three Months Ended				Six Months Ended
			June 30,				June 30,
		2025		2024		2025		2024
Sale of Services
United States	\$	20,680	\$	18,646	\$	41,401	\$	34,643
Europe		4,507		1,936		7,985		4,438
Israel		1,670		1,283		3,273		2,494
Other		3,784		2,928		7,400		5,371

b. Contract liabilities:

	June 30, 2025	December 31, 2024
Opening balance	\$ 6,928	\$ 5,239
Revenue deferrals	1,578	7,012
Revenue recognized	(2,555)	(5,323)
Closing balance	\$ 5,951	\$ 6,928

U.S. dollars in thousands

NOTE 9 – SUBSEQUENT EVENTS

On July 4, 2025, the United States enacted tax reform legislation through the One Big Beautiful Bill Act, which changes existing U.S. tax laws, including extending or making permanent certain provisions of the Tax Cuts and Jobs Act, repealing certain clean energy initiatives, in addition to other changes. The Company is still in the process of evaluating the impact of this new legislation to provision for income taxes, deferred tax assets, deferred tax liabilities, and to income taxes payable in the period of enactment and will continue to assess the impact the new legislation will have on the consolidated financial statements.

TAT TECHNOLOGIES LTD.

Operating and Financial Review and Prospects

You should read the following discussion and analysis of our financial condition and results of operations together with (i) our unaudited condensed consolidated financial statements as of June 30, 2025 and for the three and six months ended June 30, 2025, included as Exhibit 99.1 to this Report on Form 6-K (this "Report"), (ii) our audited consolidated financial statements and other financial information as of and for the year ended December 31, 2024 appearing in our Annual Report on Form 20-F for the year ended December 31, 2024 (our "Annual Report") and (iii) Item 5 — "Operating and Financial Review and Prospects" of our Annual Report. Some of the information contained in this discussion and analysis, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set forth in the section entitled "Cautionary Statement Regarding Forward-Looking Statement" and in the section entitled Item 3.D. "Risk Factors" of our Annual Report, our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.

Unless otherwise designated, the terms "we", "us", "our", "TAT", "the Company" and "our company" refer to TAT Technologies Ltd.

All references in this Report to "dollar," "USD" or "\$" refer to U.S. dollars and the terms "Israeli currency", "NIS", and "ILS" refer to Israeli New Shekels.

Cautionary Statement Regarding Forward-Looking Statements

Statements in this Report may constitute "forward-looking statements" within the meaning of the United States federal securities laws. These forward-looking statements can generally be identified as such because the context of the statement will include words such as "may," "might," "will," "could," "would," "intends," "plans," "believes," "anticipates," "expects," "seeks," "estimates," "predicts," "potential," "continue," "contemplate" or "opportunity," the negative of these words or words of similar import. Similarly, statements that describe our business outlook or future economic performance, anticipated revenues, expenses or other financial items, introductions and advancements in development of products, and plans and objectives related thereto, and statements concerning assumptions made or expectations as to any future events, conditions, performance or other matters, are also forward-looking statements. Forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those stated in such statements. Factors that could cause or contribute to such differences include, but are not limited to, those set forth in Item 3.D. "Risk Factors" in our Annual Report, as well as those discussed elsewhere in our Annual Report and in our other filings with the Securities and Exchange Commission.

Company Overview

TAT is reliant on the robustness of the commercial and military aerospace and ground defense industries. Any downturn in these industries could weaken demand for its solutions and services and negatively impact its financial results. The commercial airline industry is cyclical and has historically been subject to fluctuations due to general economic and political conditions, such as fuel and labor costs, price competition, downturns in the global economy and national and international events.

TAT's cost of revenues for OEM operations and MRO services consists of component and material costs, direct labor costs, quality assurance costs, shipping expenses, royalties, overhead related to manufacturing and depreciation of manufacturing equipment. TAT's gross margin is affected by the proportion of its revenues generated from each of its operational segments.

The principal factors that affect the operating income of TAT's four segments, in addition to their gross profit, are the expenditures on sales and marketing expenses and general and administrative expenses. While TAT closely monitors its operating expenses to prevent unnecessary spending, we believe that these operating expenses may increase in the future in accordance with our plans to grow the business.

TAT's research and development expenses are related to new products and technologies or significant improvement of existing products and technologies.

TAT's selling and marketing expenses are related to commission payments, compensation and related expenses of TAT's sales teams, participation in trade shows, travel expenses, advertising expenses and related costs for facilities and equipment.

TAT's general and administrative expenses are related to compensation and related expenses for executive, finance and administrative personnel, professional fees such as legal, audit, SOX, internal audit, insurance premiums and general corporate expenses and related costs for facilities and equipment.

Results of operations

TAT's management evaluates its performance by focusing on key performance indicators, which are revenues, sources of revenues, gross profit and operating income. These key performance indicators are primarily affected by the competitive landscape in which TAT operates and its ability to meet the challenges posed.

The results of operations presented below should be reviewed in conjunction with the unaudited condensed consolidated financial statements as of June 30, 2025 and for the three months and six months ended June 30, 2025 and 2024, included in Exhibit 99.1 to this Report, our audited consolidated financial statements as of and for the year ended December 31, 2024 appearing in our Annual Report, and Item 5 - "Operating and Financial Review and Prospects" of our Annual Report.

The following table presents, for the periods indicated, information concerning TAT's results of operations:

		Three months ended June 30,				Six months ended June 30,
	2025		2024		2025		2024
U.S. dollars in thousands	Amount	%	Amount	%	Amount	%	Amount	%
Revenues:
Products	\$ 12,463	28.9%	\$ 11,732	32.1%	\$ 25,187	29.5%	\$ 23,667	33.5%
Services	30,641	71.1%	24,793	67.9%	60,059	70.5%	46,946	66.5%
	43,104	100.0%	36,525	100.0%	85,246	100.0%	70,613	100.0%
Cost of goods:
Products	9,112	21.1%	7,673	21.0%	17,443	20.5%	16,659	23.6%
Services	23,167	53.7%	20,868	57.1%	47,024	55.2%	38,904	55.1%
	32,279	74.9%	28,541	78.1%	64,467	75.6%	55,563	78.7%
Gross profit	10,825	25.1%	7,984	21.9%	20,779	24.4%	15,050	21.3%
Operating expenses:
Research and development, net	240	0.6%	343	0.9%	564	0.7%	620	0.9%
Selling and marketing	2,185	5.1%	1,993	5.5%	4,113	4.8%	3,653	5.2%
General and administrative	3,965	9.2%	2,916	8.0%	7,497	8.8%	6,225	8.8%
Other income			(2)	0.0%	-	-	(390)	(0.6)%
	6,390	14.8%	5,250	14.4%	12,174	14.3%	10,108	14.3%
Operating income	4,435	10.3%	2,734	7.5%	8,605	10.1%	4,942	7.0%
Interest expenses	(324)	(0.8)%	(413)	(1.1)%	(659)	(0.8)%	(763)	(1.1)%
Other financial income (expenses), net	(776)	(1.8)%	106	0.3%	(499)	(0.6)%	7	0.0%
Income before taxes on income (taxes
benefit)	3,335	7.7%	2,427	6.6%	7,447	8.7%	4,186	5.9%
Provision for taxes on income (taxes
benefit)	211	0.5%	44	0.1%	803	0.9%	(109)	(0.2)%
Profit before share of equity investment	3,124	7.2%	2,383	6.5%	6,644	7.8%	4,295	6.1%
Share in profits of equity investment of
affiliated companies	318	0.7%	234	0.6%	611	0.7%	432	0.6%
Net income	\$ 3,442	8.0%	\$ 2,617	7.2%	\$ 7,255	8.5%	\$ 4,727	6.7%
			3

Revenues

TAT, directly and through its subsidiaries, provides a variety of solutions and services to the commercial and military aerospace and ground defense industries, including:

• (i) OEM of heat transfer solutions and aviation components, such as heat exchangers, pre-coolers and oil/fuel hydraulic coolers (through TAT Israel);
• (ii) MRO services for heat transfer components and OEM of heat transfer solutions (through our Limco subsidiary);
• (iii) MRO services for aviation components (through our Piedmont subsidiary); and
• (iv) Overhaul and coating of jet engine components (through our Turbochrome subsidiary).

		Three months ended June 30,		Change	Six months ended June 30,		Change
U.S. dollars in thousands		2025	2024	\$	%	2025	2024		\$	%
OEM of heat transfer solutions and
aviation accessories	\$	9,661	\$ 9,589	\$ 72	0.8%	\$ 20,084	\$ 18,889	\$	1,195	6.3%
MRO services for heat transfer components and OEM of heat transfer
solutions		11,525	10,948	577	5.3%	23,665	20,958		2,707	12.9%
MRO services for aviation components		19,996	15,191	4,805	31.6%	38,294	29,163		9,131	31.3%
Overhaul and coating of jet engine
components		2,252	1,747	505	28.9%	4,438	3,609		829	23.0%
Eliminations		(330)	(950)	620	(65.3)%	(1,235)	(2,006)		771	(38.4)%
Total revenue	\$	43,104	\$ 36,525	\$ 6,579	18.0%	\$ 85,246	\$ 70,613	\$	14,633	20.7%

Total revenues were \$43.1 million for the three months ended June 30, 2025, compared to \$36.5 million for the three months ended June 30, 2024, an increase of 18.0%. Total revenues were \$85.2 million for the six months ended June 30, 2025, compared to \$70.6 million for the six months ended June 30, 2024, an increase of 20.7%. This reflects (i) the increase in revenues in the OEM of heat transfer solutions and aviation accessories segment; (ii) the increase in revenues in the MRO services for heat transfer components and OEM of heat transfer solutions segment; (iii) the increase in revenues in the MRO services for aviation components segment; and (iv) the increase in revenue in the overhaul and coating of jet engine components segment.

Cost of revenues

TAT's cost of revenues for OEM operations and MRO services consists of component and material costs, direct and indirect labor costs, quality assurance costs, royalties, shipping expenses, overhead related to manufacturing and depreciation of manufacturing equipment.

TAT's gross margin was affected by the proportion of TAT's revenues generated from OEM operations and MRO services in each of the reported periods.

		Three months ended	June 30,		Change	Six months ended	June 30,		Change
U.S. dollars in thousands		2025		2024	\$	%	2025		2024	\$	%
OEM of heat transfer solutions and aviation accessories	\$	6,714	\$	5,936	778	13.1%	\$ 13,887	\$	12,275	\$ 1,612	13.1%
MRO services for heat transfer components and OEM of heat transfer
solutions		8,139		9,497	(1,358)	(14.3)%	16,962		17,632	(670)	(3.8)%
MRO services for aviation components		16,700		12,832	3,868	30.1%	32,745		25,396	7,349	28.9%
Overhaul and coating of jet engine
components		1,083		1,101	(18)	(1.6)%	2,191		2,186	5	0.2%
Eliminations		(357)		(825)	468	(56.7)%	(1,318)		(1,926)	608	(31.6)%
Total cost of revenue		32,279		28,541	3,738	13.1%	64,467		55,563	8,904	16.0%
Gross profit	\$	10,825	\$	7,984	2,841	35.6%	\$ 20,779	\$	15,050	\$ 5,729	38.1%

Cost of revenues was \$32.3 million for the three months ended June 30, 2025, compared to \$28.5 million for the three months ended June 30, 2024, an increase of 13.1%. Cost of revenues as a percentage of revenues decreased to 74.9% for the three months ended June 30, 2025, from 78.1% for the three months ended June 30, 2024.

Cost of revenues was \$64.5 million for the six months ended June 30, 2025, compared to \$55.6 million for the six months ended June 30, 2024, an increase of 16.0%. Cost of revenues as a percentage of revenues decreased to 75.6% for the six months ended June 30, 2025, from 78.7% for the six months ended June 30, 2024.

The increase in cost of revenues is primarily due to the increase in revenue in a higher percentage compared to the increase in our fixed costs.

Operating expenses

Research and development expenses, net

Research and development expenses, net are related to new products and technologies or to a significant improvement of products and technologies, net of grants and participations received.

Selling and marketing expenses

Selling and marketing expenses consist primarily of commission payments, compensation and related expenses of TAT's sales teams, participation in trade shows, travel expenses, advertising expenses and related costs for facilities and equipment.

General and administrative expenses

General and administrative expenses consist of compensation and related expenses for executive, finance and administrative personnel, professional fees such as legal, audit, SOX, internal audit, other general corporate expenses and related costs for facilities and equipment.

		Three months ended				Six months ended
	June 30,					Change				June 30,			Change
U.S. dollars in thousands		2025		2024		\$	%		2025		2024		\$	%
Research and development, net	\$	240	\$	343	\$	(103)	(30.0)% \$		564	\$	620	\$	(56)	(9.0)%
Selling and marketing		2,185		1,993		192	9.6%		4,113		3,653		460	12.6%
General and administrative		3,965		2,916		1,049	36.0%		7,497		6,225		1,272	20.4%
Other income		-		(2)		2	(100)%		-		(390)		390	(100)%
Total operating expenses	\$	6,390	\$	5,250	\$	1,140	21.7%	\$	12,174	\$	10,108	\$	2,066	20.4%

Research and development, net

Research and development expenses is decrease by 30.0% to \$0.2 million for the three months ended June 30, 2025, from \$0.3 million for the three months ended June 30, 2024. Research and development expenses as a percentage of revenues were 0.6% for the three months ended June 30, 2025, compared to 0.9% for the three months ended June 30, 2024. The Company received a \$0.1 million grant from the Israeli government in June 2025 which was accounted for a credit to research and development expenses.

Research and development expenses is slightly decrease by 9.0% to \$0.6 million for the six months ended June 30, 2025, from \$0.6 million for the six months ended June 30, 2024. Research and development expenses as a percentage of revenues were 0.7% for the six months ended June 30, 2025, compared to 0.9% for the six months ended June 30, 2024. The Company received a \$0.1 million grant from the Israeli government in June 2025 which was accounted for a credit to research and development expenses.

Selling and marketing

Selling and marketing expenses were \$2.2 million for the three months ended June 30, 2025, compared to \$2.0 million for the three months ended June 30, 2024, an increase of 9.6%. Selling and marketing expenses as a percentage of revenues were 5.1% for the three months ended June 30, 2025, compared to 5.5% for the three months ended June 30, 2024.

Selling and marketing expenses were \$4.1 million for the six months ended June 30, 2025, compared to \$3.7 million for the six months ended June 30, 2024, an increase of \$12.6%. Selling and marketing expenses as a percentage of revenues were 4.8% for the six months ended June 30, 2025, compared to 5.2% for the six months ended June 30, 2024.

General and administrative

General and administrative expenses were \$4.0 million for the three months ended June 30, 2025, compared to \$2.9 million for the three months ended June 30, 2024, an increase of 36.0% primarily due to increases in personnel-related expenses mainly from additional headcount, merit increases and stock-based compensation; in legal and professional services fees; and publicly company related expenses. General and administrative expenses as a percentage of revenues were 9.2% for the three months ended June 30, 2025, compared to 8.0% for the three months ended June 30, 2024.

General and administrative expenses were \$7.5 million for the six months ended June 30, 2025, compared to \$6.2 million for the six months ended June 30, 2024, an increase of 20.4% primarily due to increases in personnel-related expenses mainly from additional headcount, merit increases and stock-based compensation; in legal and professional services fees; and publicly company related expenses. General and administrative expenses as a percentage of revenues were 8.8% for the six months ended June 30, 2025, compared to 8.8% for the six months ended June 30, 2024.

Other expenses (income)

Interest expenses, net

Interest expenses, net consist of interest income and expense. Interest income and expenses relate to the interest received from or paid to banks for the outstanding deposits and debts, respectively.

Other financial income (expense), net

Other financial income (expense) included foreign exchange gain (loss) for the changes in rate of the NIS or other currencies against the U.S. dollar.

Provision for taxes on income (tax benefit)

Tax expense consists of Israeli and U.S. federal and state taxes on the income of TAT's business and changes in deferred tax assets or liabilities.

	Three months ended	June 30,		Change				Six months ended	June 30,		Change
U.S. dollars in thousands	2025		2024		\$	%		2025		2024	\$	%
Interest expenses, net	\$ (324)	\$	(413)	\$	89	(21.5)% \$		(659)	\$	(763)	\$ 104	(13.6)%
Other financial income (expenses), net	(776)		106		(882)	(832.1)%		(499)		7	(506)	(7,228.6)%
Provision for taxes on income (taxes benefit)	211		44		167	379.5%		803		(109)	912	(836.7)%
Share in profits of equity investment of affiliated companies	318		234		84	35.9%		611		432	179	41.4%
					7

Interest expenses, net

Interest expense, net for the three months ended June 30, 2025 were \$0.3 million, compared to \$0.4 million of interest expenses for the three months ended June 30, 2024. Interest expense as a percentage of revenues was 0.8% for the three months ended June 30, 2025, compared to 1.1% for the three months ended June 30, 2024.

Interest expense, net for the six months ended June 30, 2025 were \$0.7 million, compared to \$0.8 million of interest expenses for the six months ended June 30, 2024. Interest expense as a percentage of revenues was 0.8% for the six months ended June 30, 2025, compared to 1.1% for the six months ended June 30, 2024.

Other financial income (expenses), net

Other financial expenses, net were \$0.8 million for the three months ended June 30, 2025, compared to \$0.1 million in other financial income for the three months ended June 30, 2024. The increase was mainly due to revaluation of long-term loans in Israeli Shekel which were negatively affected by unfavorable changes in exchange rates of U.S. dollar and ILS during the second quarter of 2025. Other financial expense as a percentage of revenues were 1.8% for the three months ended June 30, 2025, compared to 0.3% for the three months ended June 30, 2024.

Other financial expenses, net were \$0.5 million for the six months ended June 30, 2025, compared to \$7 thousand in other financial income for the six months ended June 30, 2024. The increase was mainly due to revaluation of long-term loans in Israeli Shekel which were negatively affected by unfavorable changes in exchange rates of U.S. dollar and ILS during the second quarter of 2025. Other financial expense as a percentage of revenues were 0.6% for the six months ended June 30, 2025, compared to 0% for the six months ended June 30, 2024.

Provision for taxes on income (taxes benefit)

Taxes on income for the three months ended June 30, 2025, amounted to \$0.2 million, compared to \$44 thousand for the three months ended June 30, 2024. Provision for taxes on income as a percentage of revenues was 0.5% for the three months ended June 30, 2025, compared to 0.1% for the three months ended June 30, 2024.

Taxes on income for the six months ended June 30, 2025, amounted to \$0.8 million, compared to \$0.1 million tax benefits for the six months ended June 30, 2024. Provision for taxes on income as a percentage of revenues was 0.9% for the six months ended June 30, 2025, compared to 0.2% taxes benefit for the six months ended June 30, 2024. These are non-cash expenses as the company has sufficient carry forward losses to cover the ongoing profits. The company believe that the ongoing profits for the remaining of 2025 will consume the carry forward losses for both the Israel and the US entities.

Share in profits of equity investment of affiliated companies

Share in profits of equity investment of affiliated companies for the three months ended June 30, 2025, amounted to a gain of \$0.3 million compared to a gain of \$0.2 million for the three months ended June 30, 2024.

Share in profits of equity investment of affiliated companies for the six months ended June 30, 2025, amounted to a gain of \$0.6 million compared to a gain of \$0.4 million for the six months ended June 30, 2024.

Liquidity and Capital Resources

On June 3, 2025, the Company completed a public offering of 1,625,000 of its ordinary shares, no par value per share, at a public offering price of \$26.00 per share for gross proceeds of \$42.3 million. The issuance costs incurred were \$2.8 million, hence, generating net proceeds of \$39.4 million.

On June 26, 2025, the underwriters exercised in full their option to purchase an additional 242,298 ordinary shares from the Company at offering price of \$26.00. The issuance costs incurred were \$0.4 million. This resulted in additional net proceeds of approximately \$6.0 million to the Company.

The net proceeds for the Company from this public offering after issuance costs is \$45.4 million.

As of June 30, 2025, TAT had cash and cash equivalents of \$43.1 million compared to \$7.1 million as of December 31, 2024, an increase of \$36.0 million primarily due to the June 2025, public offering as previously discussed.

During the six months ended June 30, 2025, TAT decreased its loans and lines of credit from commercial banks by \$5.0 million.

Capital expenditures for the six months period ended June 30, 2025 were approximately \$6.2 million. TAT funded these capital expenditures mainly from its own cash resources and cash flows from operations. TAT expects that its available cash and cash equivalents and cash flow generated from operations will be sufficient to fund its future capital expenditures.

TAT's management believes that anticipated cash flow from operations and its current cash balances will be sufficient to meet its cash requirements for at least 12 months from the issuance date of the unaudited financial statements. TAT's future capital requirements will depend on many factors, including its rate of revenue growth, the expansion of its selling and marketing activities, costs associated with expansion into new markets and the timing of the introduction of new products and services.

Cash Flows

The following table summarizes TAT's statements cash flows for the periods presented:

	Three months ended June 30,	Six months ended June 30,
U.S. dollars in thousands	2025	2024			2025		2024
Net cash provided by (used in) operating activities	\$ 6,949	\$	(4,100)	\$	1,914	\$	(7,647)
Net cash used in investing activities	(3,305)		(978)		(6,167)		(661)
Net cash provided by (used in) financing activities	34,495		4,157		40,293		(282)
Net increase (decrease) in cash and cash equivalents	38,139		(921)		36,040		(8,590)
Cash and cash equivalents and restricted cash at beginning of the period	5,335		9,273		7,434		16,942
Cash and cash equivalents and restricted cash at end of the period	\$ 43,474	\$	8,352	\$	43,474	\$	8,352

Net cash provided by operating activities for the three months ended June 30, 2025, amounted to approximately \$6.9 million, compared to net cash used in operating activities of \$(4.1) million for the three months June 30, 2024. Net cash provided by operating activities for the six months ended June 30, 2025, amounted to approximately \$1.9 million, compared to net cash used in operating activities of \$(7.6) million for the six months June 30, 2024.

Net cash provided by operating activities for the three months ended June 30, 2025 was principally derived from our upward in our net income to \$3.4 million and also from the following adjustments of non-cash line items: an upward adjustment of \$1.2 million for depreciation and amortization; an upward adjustment of \$3.0 million for an increase in trade accounts payable; an upward adjustment of \$0.9 million for an decrease in trade accounts receivable; an offset adjustment of \$3.4 million for inventory; and a downward adjustment of \$0.5 million for decrease in accrued expenses and other. Net cash provided by operating activities for the six months ended June 30, 2025 was principally derived from our upward in our net income to \$7.3 million and also from the following adjustments of non-cash line items: an upward adjustment of \$2.5 million for depreciation and amortization; an upward adjustment of \$3.4 million for an increase in trade accounts payable; an offset adjustment of \$2.6 million for an increase in trade accounts receivable; an offset adjustment of \$7.3 million for inventory; and a downward adjustment of \$3.6 million for decrease in accrued expenses and other.

Net cash used in operating activities for the three months ended June 30, 2024 was principally derived from the following adjustments of non-cash line items: an upward adjustment of \$1.4 million for depreciation and amortization; an offset adjustment of \$2.9 million for inventory; a downward adjustment of \$5.4 million for increase in trade accounts receivable and an upward adjustment of \$0.6 million for increase in accrued expenses and other. Net cash used in operating activities for the six months ended June 30, 2024 was principally derived from the following adjustments of non-cash line items: an upward adjustment of \$2.8 million for depreciation and amortization; an offset adjustment of \$5.5 million for inventory; a downward adjustment of \$6.2 million for increase in trade accounts receivable and a downward adjustment of \$1.0 million for decrease in accrued expenses and other.

For the three months ended June 30, 2025, net cash used by investing activities was \$3.3 million, substantially attributed to investment mainly in machinery and equipment. For the six months ended June 30, 2025, net cash used by investing activities was \$6.2 million, out of which approximately \$.6.2 million was attributed to investment mainly in machinery and equipment.

For the three months ended June 30, 2024, net cash used in investing activities was \$1.0 million, substantially attributed to investment mainly in machinery and equipment. For the six months ended June 30, 2024, net cash used by investing activities was \$0.7 million, out of which approximately \$2.0 million was attributed to investment mainly in machinery and buildings offset by \$1.3 million proceeds from sale of machinery and equipment.

For the three months ended June 30, 2025, net cash provided by financing activities was \$34.5 million. Net cash provided by financing activities was primarily attributable to the \$48.6 million gross proceeds from issuance of ordinary shares, offset by the issuance costs of \$2.8 million and \$11.2 million repayments of short-term credit line and long-term loans. For the six months ended June 30, 2025, net cash provided by financing activities was \$40.3 million. Net cash provided by financing activities was primarily attributable to the \$48.6 million gross proceeds from the issuance of ordinary shares, offset by the issuance costs of \$2.8 million and \$5.4 million repayments of short-term credit line and long-term loans.

For the three months ended June 30, 2024, net cash used by financing activities was \$4.2 million, primarily from proceeds of short-term loan of \$4.7 million offset by \$0.5 million repayment of long-term loans. For the six months ended June 30, 2024, net cash used by financing activities was \$0.3 million, primarily from proceeds of short-term loan of \$0.7 million offset by \$1.0 million repayment of long-term loans.

Off-Balance Sheet Arrangements

We are not a party to any material off-balance sheet arrangements. In addition, we have no unconsolidated special purpose financing or partnership entities that are likely to create material contingent obligations.